Shuttle Peptide Delivers Base Editor RNPs to Rhesus Monkey Airway Epithelial Cells

adenine base editor cystic fibrosis ribonucleoprotein

Journal

Research square
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035

Informations de publication

Date de publication:
17 Feb 2023
Historique:
pubmed: 25 2 2023
medline: 25 2 2023
entrez: 24 2 2023
Statut: epublish

Résumé

Gene editing strategies for cystic fibrosis are challenged by the complex barrier properties of airway epithelia. We previously reported that the amphiphilic S10 shuttle peptide non-covalently combined with CRISPR-associated (Cas) ribonucleoprotein (RNP) enabled editing of human and mouse airway epithelial cells. Here, to improve base editor RNP delivery, we optimized S10 to derive the S315 peptide. Following intratracheal aerosol of Cy5-labeled peptide cargo in rhesus macaques, we confirmed delivery throughout the respiratory tract. Subsequently, we targeted

Identifiants

pubmed: 36824928
doi: 10.21203/rs.3.rs-2540755/v1
pmc: PMC9949254
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : UG3 AI150551
Pays : United States
Organisme : NHLBI NIH HHS
ID : K99 HL163805
Pays : United States
Organisme : NIH HHS
ID : S10 OD016261
Pays : United States
Organisme : NHLBI NIH HHS
ID : P01 HL152960
Pays : United States
Organisme : NIH HHS
ID : P51 OD011107
Pays : United States
Organisme : NHLBI NIH HHS
ID : R00 HL163805
Pays : United States
Organisme : NHLBI NIH HHS
ID : UG3 HL147366
Pays : United States
Organisme : NCRR NIH HHS
ID : S10 RR025063
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI142756
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK054759
Pays : United States
Organisme : NIH HHS
ID : S10 OD028713
Pays : United States
Organisme : NHGRI NIH HHS
ID : U24 HG010423
Pays : United States
Organisme : NIH HHS
ID : U42 OD027094
Pays : United States

Auteurs

Katarina Kulhankova (K)

University of Iowa.

Soumba Traore (S)

University of Iowa.

Xue Cheng (X)

Feldan Therapeutics.

Hadrien Benk-Fortin (H)

Feldan Therapeutics.

Stéphanie Hallée (S)

Feldan Therapeutics.

Mario Harvey (M)

Feldan Therapeutics.

Joannie Roberge (J)

Feldan Therapeutics.

Gregory Newby (G)

Broad Institute.

David Liu (D)

Broad Institute.

Alice Tarantal (A)

University of California - Davis.

David Guay (D)

Feldan Therapeutics.

Classifications MeSH